Kinetics of immunologic responses after primary MMR vaccination

被引:55
作者
Pabst, HF [1 ]
Spady, DW [1 ]
Carson, MM [1 ]
Stelfox, HT [1 ]
Beeler, JA [1 ]
Krezolek, MP [1 ]
机构
[1] US FDA, DIV VIRAL PROD, BETHESDA, MD 20014 USA
关键词
immunologic responses; measles; vaccination; infants;
D O I
10.1016/S0264-410X(96)00124-7
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To study the kinetics of humoral as well as cellular immunity to measles and to test for associated immunosuppression 124 12 month old children were studied twice, before routine MMR and either 14, 22, 30, or 38 days after vaccination. Plaque reduction neutralization (PRN) titres were determined at these time points and lymphocytes were evaluated to identify changes in proportions of phenotype, their capacity to generate cytokines and to respond to blast transformation (BT) to measles hemagglutinin (HA), tetanus toroid, and Candida antigen. The PRN titre and BT to HA plateaued at 30 days and CD8+ and NK cells increased after immunization. Interleukin 2, 4, and 10 showed no significant changes. There was mild suppression of BT at 14 and 22 days postimmunization. Interferon-gamma was the principal cytokine produced after primary measles immunization, suggesting primary measles immunization induces predominantly, a TH1 type response. Copyright (C) 1997 Published by Elsevier Science Ltd.
引用
收藏
页码:10 / 14
页数:5
相关论文
共 24 条
  • [1] ROLE OF VIRUS-STRAIN IN CONVENTIONAL AND ENHANCED MEASLES PLAQUE NEUTRALIZATION TEST
    ALBRECHT, P
    HERRMANN, K
    BURNS, GR
    [J]. JOURNAL OF VIROLOGICAL METHODS, 1981, 3 (05) : 251 - 260
  • [2] LIVE RUBELLA VIRUS VACCINE IN TUBERCULOUS CHILDREN
    BERKOVICH, S
    STEINER, P
    STEINER, M
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1969, 118 (02): : 252 - +
  • [3] MEASLES VACCINATION OF INFANTS IN A WELL-VACCINATED POPULATION
    CARSON, MM
    SPADY, DW
    ALBRECHT, P
    BEELER, JA
    THIPPHAWONG, J
    BARRETO, L
    GRIMSRUD, KM
    PABST, HF
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (01) : 17 - 22
  • [4] MEASLES ANTIBODY - REEVALUATION OF PROTECTIVE TITERS
    CHEN, RT
    MARKOWITZ, LE
    ALBRECHT, P
    STEWART, JA
    MOFENSON, LM
    PREBLUD, SR
    ORENSTEIN, WA
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (05) : 1036 - 1042
  • [5] CHILD-MORTALITY AFTER HIGH-TITER MEASLES-VACCINES - PROSPECTIVE-STUDY IN SENEGAL
    GARENNE, M
    LEROY, O
    BEAU, JP
    SENE, I
    [J]. LANCET, 1991, 338 (8772) : 903 - 907
  • [6] GOOD RA, 1956, PEDIATRICS, V18, P109
  • [7] DIFFERENTIAL CD4 T-CELL ACTIVATION IN MEASLES
    GRIFFIN, DE
    WARD, BJ
    [J]. JOURNAL OF INFECTIOUS DISEASES, 1993, 168 (02) : 275 - 281
  • [8] HALL CB, 1972, J IMMUNOL, V108, P81
  • [9] MEASLES-VIRUS VACCINATION OF MEASLES SEROPOSITIVE INDIVIDUALS SUPPRESSES LYMPHOCYTE-PROLIFERATION AND CHEMOTACTIC FACTOR PRODUCTION
    HIRSCH, RL
    MOKHTARIAN, F
    GRIFFIN, DE
    BROOKS, BR
    HESS, J
    JOHNSON, RT
    [J]. CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1981, 21 (03): : 341 - 350
  • [10] EFFECT OF HPV-80 RUBELLA VACCINE ON TUBERCULIN REACTION
    LAMB, GA
    [J]. AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1969, 118 (02): : 261 - &